NET EDUCATIONAL EVENT
What's New in PRRT
Friday, April 14, 2023
12 PM Pacific
Join Dr. Amir Iravani, a Nuclear Medicine Physician and Theranostics Director at Fred Hutchinson Cancer Center, to hear the latest on Peptide Receptor Radionuclide Therapy (PRRT). Better understand the difference between beta and alpha PRRT, current trials and updates on PRRT for Lung NET, adolescents and dosimetry.
Registration is required. Please register below.
Have a question about PRRT? A live Question & Answer session will follow the presentation. To submit your general question, go to https://www.slido.com/LACNETS5.
ABOUT THE SPEAKER
Amir Iravani, MD, FRACP
Associate Professor
University of Washington, Department of Radiology
Theranostics Director, Fred Hutchinson Cancer Center
Dr. Iravani is a nuclear medicine physician and an Associate Professor of Radiology at the University of Washington and the Theranostics Director at Fred Hutchinson Cancer Center. Before his current role, he worked at the Center for Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Center (PMCC), Melbourne, Australia. He finished training in Nuclear Medicine and Internal Medicine and became a fellow of the Royal College of Physicians in Australia. Dr. Iravani’s fellowship was in Molecular Imaging and Radiopharmaceutical Therapy at PMCC.
Dr. Iravani has been actively involved in multiple practice-changing theranostic clinical trials and contributed to multiple seminal publications in this field. He is currently a member of multiple national committees in theranostics, including the board of directors of the Society of Nuclear Medicine and Molecular Imaging Theranostic Center of Excellence and the PRRT dosimetry working group at the National Cancer Institute.
REGISTRATION FORM
THANKS TO OUR SPONSORS
